Concepedia

Gerry Hagan

GH

16

Publications

3K

Citations

14

H-Index

2003

Active since

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

GlaxoSmithKline (Japan)

University College London

St George's, University of London

St George's Hospital

Gerry Hagan is an author at GlaxoSmithKline (United Kingdom) specializing in pulmonary disease, medicine, and inflammatory lung disease.

Top concepts

Publications per year

2003–2016

16

Publications

16

The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide

Jadwiga A. Wedzicha, Peter M.A. Calverley, Terence Seemungal et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 838 citations

Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)

Jørgen Vestbo, W. J. Anderson, Harvey O. Coxson et al. · European Respiratory Journal · 2008 · 747 citations · Full text

, , +13

Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease

John R. Hurst, Gavin C. Donaldson, Wayomi R. Perera et al. · American Journal of Respiratory and Critical Care Medicine · 2006 · 457 citations

The natural history of community-acquired pneumonia in COPD patients: A population database analysis

Hana Müllerová, Chuba Chigbo, Gerry Hagan et al. · Respiratory Medicine · 2012 · 201 citations · Full text

, , +5

Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD

Dave Singh, Jean Brooks, Gerry Hagan et al. · Thorax · 2008 · 177 citations · Full text

Rows per page

1–5 of 16